Skip to main content

Media Category: x - Webinars

Update on Neuroimaging Techniques to Detect Activity and Progression in MS: The Role of Novel Markers for Chronic Active Inflammation (PRLs, SELs)

•The central vein sign could be used for differential diagnosis. •PRLs appear in the early stages and are more common in inflammatory stages. •PRLs are related to more aggressive disease •Brain atrophy assessed could help us to assess progression •Smouldering MS and progressive MS can be imaged using classic and novel techniques •SELs are related to progressive phases of the disease BIOGRAPHY CELIA OREJA-GUEVARA Prof. Celia Oreja-Guevara is Vice Chair of Neurology and Head of Multiple Sclerosis Center at the University Hospital San Carlos, Madrid and Professor...

Continue reading

Patient-reported Outcomes: Novel Examination Techniques to Uncover Disability Accumulation

Identification of progression needs new (digital) tools: •Which can monitor different symptoma domains •Which can assessment neurological function in a quantitative way •Which are sensitive enough to detect even subtle changes Patient-reported outcomes can assist using innovative instruments to detect progression from the patient perspective. Data should be collected and analyzed on one platform. BIOGRAPHYTJALF ZIEMSSENProf. Tjalf Ziemssen, MD, is Professor of Clinical Neuroscience in the Department of Neurology, Head of the Multiple Sclerosis Center and Neuroimmunological...

Continue reading

Immunological Players in the Pathogenesis of MS

Inflammation is the driving force in the pathogenesis of MS. Over the past decades, we can observe increased recognition that various immune cells are involved: [CD4+ Tc, CD8+ Tc, macrophages] plus Bc plus microglia. As a consequence of gained knowledge in the immunopathogenesis of MS -> DMTs are, thus, increasingly developed towards targeted treatments (at the right time of the disease course…).  BIOGRAPHY THOMAS BERGER Prof. Thomas Berger, MD, MSc, FEAN, is Professor of Neurology and Chair of the Dept. of Neurology as well as Chair of the Comprehensive Center...

Continue reading

Real-life data on switching medication 

BIOGRAPHY MELINDA MAGYARI Melinda Magyari is the director of The Danish Multiple Sclerosis Registry (link: and a consultant neurologist at the Danish Multiple Sclerosis Center (COI). Her major research area is in multiple sclerosis and other inflammatory disorders of the central nervous system with a special interest in the changing epidemiology and gender differences. Using nationwide population-based data sources her research addresses questions on comorbidities, reproductive issues, risk factors and socioeconomic consequences in multiple sclerosis. She is involved...

Continue reading

Immunology and the mechanisms of immune system disfunction 

BIOGRAPHY Vincent van Pesch  Van Pesch served as neurology resident at the Department of Neurology, Saint-Luc Hospital and then progressed in positions from Adjunct Clinical Head to Associate Clinical Head and finally to Adjunct Chief of Neurology Department at the Cliniques Universitaires Saint-Luc (COI). He is also responsible for the coordination and supervision of the neurophysiology unit and is consultant for the clinical biology department concerning neuro-immunological analysis. He obtained his medical degree in 1999 from the UCLouvain and then completed his...

Continue reading

Epstein Barr Virus and Multiple Sclerosis: Old Wine in New Bottles?

BIOGRAPHY NIELS HELLINGS Niels Hellings is Director of the Biomedical research Institute (BIOMED) and Professor Immunology at the Faculty of Medicine and Life Sciences of Hasselt University (COI). He graduated as master in bioscience-engineering at the Catholic University of Leuven (1996) and consequently obtained a PhD in immunology at Hasselt University (2000). He was visiting postdoctoral scientist at McGill University (Montréal), before returning to Hasselt University to set up his own research group. Currently, Niels Hellings is director of the biomedical research institute...

Continue reading


Do subscriptions auto-renew?
Your subscription will automatically renew on a monthly or yearly basis, depending on the plan you have chosen. If you cancel your plan, it will not renew at the end of your subscription cycle. It will end once the period you have paid for is over.
What happens if I subscribe as a healthcare practitioner if I am not a healthcare practitioner?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, you will be banned immediately from the community and could be liable to prosecution.
How can I cancel my trial or subscription?
You can cancel your trial or subscription in your account settings. If you cancel during the trial period you will not be charged.